Insider Transactions in Q1 2025 at Kempharm, Inc (KMPH)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 14
2025
|
Neil F. Mc Farlane President and CEO |
SELL
Open market or private sale
|
Direct |
30,544
-13.75%
|
$244,352
$8.05 P/Share
|
|
Feb 13
2025
|
R. La Duane Clifton CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
11,000
-17.64%
|
$77,000
$7.86 P/Share
|
|
Feb 13
2025
|
Joshua Schafer CCO & EVP, Bus. Development |
SELL
Open market or private sale
|
Direct |
10,500
-26.26%
|
$73,500
$7.86 P/Share
|
|
Feb 13
2025
|
Timothy J. Sangiovanni SVP, Finance & Corp Controller |
SELL
Open market or private sale
|
Direct |
3,000
-15.51%
|
$21,000
$7.86 P/Share
|
|
Feb 13
2025
|
Neil F. Mc Farlane President and CEO |
SELL
Open market or private sale
|
Direct |
61,273
-21.63%
|
$428,911
$7.86 P/Share
|
|
Jan 31
2025
|
Timothy J. Sangiovanni SVP, Finance & Corp Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
11,666
+37.62%
|
-
|
|
Jan 31
2025
|
R. La Duane Clifton CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
43,333
+41.0%
|
-
|
|
Jan 31
2025
|
Joshua Schafer CCO & EVP, Bus. Development |
BUY
Exercise of conversion of derivative security
|
Direct |
35,333
+46.91%
|
-
|
|
Jan 31
2025
|
Neil F. Mc Farlane President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
233,333
+45.16%
|
-
|